A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in billary and pancreatic malignancies

被引：0
|
作者：
Leong, S. [1 ]
Obryant, C. L. [1 ]
Messersmith, W. A. [1 ]
Diab, S. [1 ]
Kane, M. A. [1 ]
Nallapreddy, S. [1 ]
Weekes, C. [1 ]
Spratlin, J. [1 ]
Call, J. [1 ]
Eckhardt, S. G. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72336-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [21] Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
    Cascone, T.
    Sacks, R. L.
    Subbiah, I. M.
    Drobnitzky, N.
    Piha-Paul, S. A.
    Hong, D. S.
    Hess, K. R.
    Amini, B.
    Bhatt, T.
    Fu, S.
    Naing, A.
    Janku, F.
    Karp, D.
    Falchook, G. S.
    Conley, A. P.
    Sherman, S., I
    Meric-Bernstam, F.
    Ryan, A. J.
    Heymach, J., V
    Subbiah, V
    ESMO OPEN, 2021, 6 (02)
  • [22] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Derek S. Serna
    Tanios Bekaii-Saab
    Eric H. Kraut
    Investigational New Drugs, 2011, 29 : 1390 - 1394
  • [23] A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors
    Doss, H. H.
    Jones, S. F.
    Infante, J. R.
    Spigel, D. R.
    Willcutt, N.
    Lamar, R.
    Barton, J.
    Keegan, M.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Serna, Derek S.
    Bekaii-Saab, Tanios
    Kraut, Eric H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1390 - 1394
  • [25] Gemcitabine and vinorelbine, a phase I study in patients with advanced malignancies
    Chaouche, M
    Delord, JP
    Raymond, E
    Vayre, L
    Ducreux, M
    Ruffle, P
    Rodier, JM
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
  • [26] Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
    Fracasso, PM
    Rader, JS
    Govindan, R
    Herzog, TJ
    Arquette, MA
    Denes, A
    Mutch, DG
    Picus, J
    Tan, BR
    Fears, CL
    Goodner, SA
    Sun, SL
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1819 - 1825
  • [27] Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial
    Hess, V
    Salzberg, M
    Borner, M
    Morant, R
    Roth, AD
    Ludwig, C
    Herrmann, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 66 - 68
  • [28] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Gore, Lia
    Rivera, E.
    Basche, M.
    Moulder-Thompson, S. L.
    Li, J.
    Eppers, S.
    Grolnic, S.
    O'Bryant, C.
    Cleere, D.
    Elsayed, Y. A.
    Eckhardt, S. G.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1942 - 1949
  • [29] Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies
    Haigentz, M
    Kim, M
    Sorich, J
    Lee, J
    Hochster, H
    Macapinlac, M
    Mirchandani, D
    Sewak, S
    Pavlick, A
    Volm, M
    Hamilton, A
    Muggia, FM
    ANTI-CANCER DRUGS, 2003, 14 (04) : 321 - 326
  • [30] Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies
    Mahadevan, Daruka
    Dreisbach, Luke
    Kristedja, Timothy
    Williams, Debbie
    Obregon, Yrma
    Kurtin, Sandy
    Von Hoff, Daniel D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (06): : 607 - 611
12345